Loading...
Bright light therapy can improve winter seasonal affective disorder (SAD), but only in some patients. To examine an alternative treatment, investigators randomized 177 community-recruited, nonsuicidal people with SAD to 6 weeks of a specifically designed cognitive behavioral therapy (CBT) or to daily light therapy per scripted protocol during the same period, both to be completed before spring (women, 84%; mean age, 46). One author developed the CBT program.
About 27% of participants had comorbid axis I diagnoses (largely anxiety disorders); 25% took antidepressant medications. Randomization was stratified by sex, the presence of axis I diagnoses, and current antidepressant medication status. CBT was administered in twice-weekly, 90-minute group sessions. It involved the usual techniques for depression; it also addressed negative thoughts related to darkness and winter weather, employed behavioral activation to schedule pleasant events, and included personalized relapse prevention strategies.
One patient receiving light therapy and 13 receiving CBT dropped out. At 6 weeks, groups showed no clinically meaningful differences. Remission rates were roughly 47% on one depression scale and 56% to 64% on another. In both groups, presence of comorbidities was associated with higher depression scores throughout.
Rohan KJ et al. Randomized trial of cognitive-behavioral therapy versus light therapy for seasonal affective disorder: Acute outcomes. Am J Psychiatry 2015 Apr 10; [e-pub]. (http://dx.doi.org/10.1176/appi.ajp.2015.14101293)
Comment
These findings suggest adding specialized CBT to the armamentarium for seasonal affective disorder, but, practically, it might be used first line only for individuals who for peculiar reasons object to being treated with bright lights. How much this specialized CBT might help patients not responding to bright-light therapy or to antidepressants with proven effectiveness for SAD remains to be demonstrated. Future studies should investigate the effectiveness of combinations and sequencing of these three modalities for specific types of patients.